|
|
Joshua M. Thurman, Danica Ljubanović, Pamela A. Royer, Damian M. Kraus, Hector Molina, Nicholas P. Barry, Gregory Proctor, Moshe Levi, V. Michael Holers
J Clin Invest. 2006;
116(2):357
doi:10.1172/JCI24521
Abstract |
Full text
| PDF

I
schemia/reperfusion (I/R) of several organs results in complement activation, but the kidney is unique in that activation after I/R occurs only via the alternative pathway. We hypothesized that selective activation of this pathway after renal I/R could occur either because of a loss of complement inhibition or from increased local synthesis of complement factors. We examined the relationship between renal complement activation after I/R and the levels and localization of intrinsic membrane complement inhibitors. We found that loss of polarity of complement receptor 1–related protein y (Crry) in the tubular epithelium preceded activation of the alternative pathway along the basolateral aspect of the tubular cells. Heterozygous gene-targeted mice that expressed lower amounts of Crry were more sensitive to ischemic injury. Furthermore, inhibition of Crry expressed by proximal tubular epithelial cells in vitro resulted in alternative pathway–mediated injury to the cells. Thus, altered expression of a complement inhibitor within the tubular epithelium appears to be a critical factor permitting activation of the alternative pathway of complement after I/R. Increased C3 mRNA and decreased factor H mRNA were also detected in the outer medulla after I/R, suggesting that altered synthesis of these factors might further contribute to complement activation in this location.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(32)
| Title and authors |
Publication |
Year |
Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model : Novel preconditioning treatment
F. Cicora, J. Roberti, D. Vasquez, D. Guerrieri, N. Lausada, P. Cicora, G. Palti, E. Chuluyan, P. Gonzalez, P. Stringa
|
Clinical & Experimental Immunology
|
2012 |
Immunotherapy for acute kidney injury
Miriam Berry, Menna R Clatworthy
|
Immunotherapy
|
2012 |
Pathophysiology of Acute Kidney Injury
David P. Basile, Melissa D. Anderson, Timothy A. Sutton
|
Comprehensive Physiology
|
2012 |
Pathophysiology of ischemic acute kidney injury
Asif A. Sharfuddin, Bruce A. Molitoris
|
Nat Rev Nephrol
|
2011 |
Pathogenesis of Acute Kidney Injury: Foundation for Clinical Practice
Gilbert R. Kinsey, Mark D. Okusa
|
American Journal of Kidney Diseases
|
2011 |
Dynamic control of the complement system by modulated expression of regulatory proteins.
Joshua M Thurman, Brandon Renner
|
Lab. Invest.
|
2011 |
The role of innate immunity in donor organ procurement
Dianne B. McKay
|
Semin Immunopathol
|
2011 |
Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury
Brandon Renner, Viviana P Ferreira, Claudio Cortes, Ryan Goldberg, Danica Ljubanovic, Michael K Pangburn, Matthew C Pickering, Stephen Tomlinson, Amanda Holland-Neidermyer, Derek Strassheim, V Michael Holers, Joshua M Thurman
|
Kidney Int
|
2011 |
Urinary organic anion transporter protein profiles in AKI
M. Kunin, E. J. Holtzman, S. Melnikov, D. Dinour
|
Nephrology Dialysis Transplantation
|
2011 |
Cellular pathophysiology of ischemic acute kidney injury
Joseph V. Bonventre, Li Yang
|
J. Clin. Invest.
|
2011 |
|